Ignite Creation Date:
2024-05-06 @ 8:23 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06362460
Status:
COMPLETED
Last Update Posted:
2024-04-16
First Post:
2024-04-08
Brief Title:
Mass Balance Study of 14CRAY1216 in Healthy Adult Male Subjects in China
Sponsor:
Guangdong Raynovent Biotech Co Ltd
Organization:
Guangdong Raynovent Biotech Co Ltd
Study Overview
Official Title:
Single-center Open-label Non-randomized and Single-dose Clinical Trial to Explore the Mass Balance of Oral Suspension of 400mg 14CRAY1216
Status:
COMPLETED
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is a single-center open-label and single-dose clinical study to evaluate the mass balance biotransformation and pharmacokinetics of 14CRAY1216 in healthy Chinese male participants revealing the overall pharmacokinetic characteristics of RAY1216
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None